• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解并满足使用生长激素注射装置者的需求。

Understanding and meeting the needs of those using growth hormone injection devices.

作者信息

Dumas Hervé, Panayiotopoulos Paris, Parker Dorothy, Pongpairochana Vincent

机构信息

Serono International SA, 15 bis Chemin des Mines, Geneva, CH-1202, Switzerland.

出版信息

BMC Endocr Disord. 2006 Oct 11;6:5. doi: 10.1186/1472-6823-6-5.

DOI:10.1186/1472-6823-6-5
PMID:17034628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1618831/
Abstract

BACKGROUND

Recombinant human growth hormone (r-hGH) is used to treat: growth hormone deficiency in children and adults; children born small for gestational age; Turner's syndrome; and chronic renal failure. r-hGH is administered by daily subcutaneous injection and may be given using a number of different administration devices. The aim of this survey was, firstly, to identify which attributes of an r-hGH administration device are considered most important to physicians, teenage patients, parents of young children requiring GH and nurses who have experience of r-hGH administration, and, secondly, to determine how they rate existing devices in each of these key attributes.

METHODS

The opinions of 67 individuals with experience in r-hGH administration were captured in discussion sessions. Parents, physicians and nurses were asked to rate 19 device attributes by completing a questionnaire, and to rank four different r-hGH administration devices (including a conceptual electronic device) in order of preference.

RESULTS

Reliability, ease of use, lack of pain during injection, safety in use, storage, and number of steps in preparation before use, during use and after were considered to be the five most desirable attributes of an r-hGH administration device. An electronic device was preferred to an automatic, multi-dose injection device, a needle-free injection device or a manual, ready-to-use, disposable injection device.

CONCLUSION

In the opinion of physicians, nurses and parents using r-hGH injection devices, an ideal device must combine reliability with simplicity, while delivering treatment with minimal pain. An electronic device, which combines many of the most useful features of existing devices with novel functions, was the preferred option for r-hGH administration.

摘要

背景

重组人生长激素(r-hGH)用于治疗:儿童和成人的生长激素缺乏症;小于胎龄儿;特纳综合征;以及慢性肾衰竭。r-hGH通过每日皮下注射给药,可使用多种不同的给药装置。本次调查的目的,首先是确定r-hGH给药装置的哪些属性对医生、青少年患者、需要生长激素治疗的幼儿的父母以及有r-hGH给药经验的护士最为重要,其次是确定他们如何对现有装置在这些关键属性方面进行评分。

方法

在讨论会上收集了67名有r-hGH给药经验的人员的意见。要求父母、医生和护士通过填写问卷对19种装置属性进行评分,并对四种不同的r-hGH给药装置(包括一种概念性电子装置)按偏好程度进行排序。

结果

可靠性、易用性、注射时无疼痛、使用安全性、储存以及使用前、使用期间和使用后的准备步骤数量被认为是r-hGH给药装置最理想的五个属性。电子装置比自动多剂量注射装置、无针注射装置或手动即用型一次性注射装置更受青睐。

结论

在使用r-hGH注射装置的医生、护士和父母看来,理想的装置必须将可靠性与简单性相结合,同时以最小的疼痛进行治疗。电子装置结合了现有装置的许多最有用的功能以及新颖的功能,是r-hGH给药的首选选项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1d2/1618831/f1642f97543f/1472-6823-6-5-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1d2/1618831/aa25adc511ba/1472-6823-6-5-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1d2/1618831/c7905a9b7d30/1472-6823-6-5-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1d2/1618831/f1642f97543f/1472-6823-6-5-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1d2/1618831/aa25adc511ba/1472-6823-6-5-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1d2/1618831/c7905a9b7d30/1472-6823-6-5-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1d2/1618831/f1642f97543f/1472-6823-6-5-3.jpg

相似文献

1
Understanding and meeting the needs of those using growth hormone injection devices.了解并满足使用生长激素注射装置者的需求。
BMC Endocr Disord. 2006 Oct 11;6:5. doi: 10.1186/1472-6823-6-5.
2
Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.与使用传统注射器和针头进行皮下注射相比,采用新型无针装置cool.click 2注射重组人生长激素的药代动力学。
BMC Clin Pharmacol. 2007 Oct 8;7:10. doi: 10.1186/1472-6904-7-10.
3
A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.一种用于注射重组人生长激素的新型笔式装置:便利性、功能性和可用性评估研究。
Patient Prefer Adherence. 2017 Dec 27;12:27-34. doi: 10.2147/PPA.S149412. eCollection 2018.
4
Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.使用 easypod™ 装置改善生长激素治疗依从性:意大利中心的经验。
Ital J Pediatr. 2018 Sep 27;44(1):113. doi: 10.1186/s13052-018-0548-z.
5
Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment.影响生长激素缺乏症(GHD)注射方案及注射装置特性患者偏好的因素:一项离散选择实验
Patient Prefer Adherence. 2020 Apr 30;14:781-793. doi: 10.2147/PPA.S239196. eCollection 2020.
6
Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use.
Curr Med Res Opin. 2007 Jul;23(7):1649-55. doi: 10.1185/030079907x210589.
7
Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.特纳综合征患者的血浆生长激素结合蛋白活性、胰岛素样生长因子I及其结合蛋白水平:短期和长期注射重组人生长激素的影响
Pediatr Res. 1995 Jan;37(1):106-11. doi: 10.1203/00006450-199501000-00020.
8
Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents.易泵™电子生长激素自动注射器的治疗依从性和患者接受度:来自 824 名儿童及其家长的调查结果。
BMC Endocr Disord. 2011 Feb 4;11:4. doi: 10.1186/1472-6823-11-4.
9
Low urinary growth hormone values in patients with Turner's syndrome.特纳综合征患者尿生长激素值偏低。
J Clin Endocrinol Metab. 1992 Mar;74(3):619-22. doi: 10.1210/jcem.74.3.1740496.
10
Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.液体人生长激素(hGH)[诺德人体生长激素简易Xx®]在生长激素缺乏的成人和儿童以及慢性肾病儿童中的可接受性
Clin Drug Investig. 2002 Sep;22(9):633-638. doi: 10.2165/00044011-200222090-00008.

引用本文的文献

1
Utilities Associated with the Treatment of Growth Hormone Deficiency (GHD): A Time Trade-off (TTO) Study in the UK and Canada.生长激素缺乏症(GHD)治疗相关效用:英国和加拿大的时间权衡(TTO)研究
Patient Relat Outcome Meas. 2025 Jan 10;16:9-21. doi: 10.2147/PROM.S479705. eCollection 2025.
2
Patient preferences for prophylactic regimens requiring regular injections in children and adolescents: a systematic review and thematic analysis.患者对儿童和青少年需要定期注射的预防方案的偏好:系统评价和主题分析。
BMJ Paediatr Open. 2024 May 20;8(1):e002450. doi: 10.1136/bmjpo-2023-002450.
3
An Augmented Reality Mobile App (Easypod AR) as a Complementary Tool in the Nurse-Led Integrated Support of Patients Receiving Recombinant Human Growth Hormone: Usability and Validation Study.

本文引用的文献

1
Final height in short children born small for gestational age treated with growth hormone.接受生长激素治疗的小于胎龄儿矮小儿童的最终身高
Pediatr Res. 2005 Feb;57(2):216-22. doi: 10.1203/01.PDR.0000148716.71231.81. Epub 2004 Dec 7.
2
Treatment of a pituitary dwarf with human growth hormone.用人生长激素治疗垂体性侏儒症。
J Clin Endocrinol Metab. 1958 Aug;18(8):901-3. doi: 10.1210/jcem-18-8-901.
3
Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle.
一款增强现实移动应用程序(Easypod AR)作为护士主导的接受重组人生长激素治疗患者综合支持的辅助工具:可用性与验证研究。
JMIR Nurs. 2023 Apr 21;6:e44355. doi: 10.2196/44355.
4
New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain.深入了解制剂变量对注射用生长激素制剂的重要性:对注射部位疼痛的潜在影响。
Front Endocrinol (Lausanne). 2022 Oct 3;13:963336. doi: 10.3389/fendo.2022.963336. eCollection 2022.
5
Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment.韩国特发性身材矮小儿童接受生长激素治疗的身高结果。
Front Endocrinol (Lausanne). 2022 Sep 7;13:925102. doi: 10.3389/fendo.2022.925102. eCollection 2022.
6
Ultrasound-Guided Knee Injections Are More Accurate Than Blind Injections: A Systematic Review of Randomized Controlled Trials.超声引导下膝关节注射比盲目注射更准确:随机对照试验的系统评价
Arthrosc Sports Med Rehabil. 2021 Jun 26;3(4):e1177-e1187. doi: 10.1016/j.asmr.2021.01.028. eCollection 2021 Aug.
7
Exploring Potentially Modifiable Factors That Influence Treatment Non-Adherence Amongst Pediatric Growth Hormone Deficiency: A Qualitative Study.探索影响儿童生长激素缺乏症治疗依从性的潜在可改变因素:一项定性研究。
Patient Prefer Adherence. 2020 Oct 13;14:1889-1899. doi: 10.2147/PPA.S268972. eCollection 2020.
8
Ease of Use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial.重组人生长激素一次性笔与可重复使用装置相比的易用性、偏好性和安全性:一项多中心、单臂、开放标签、转换、前瞻性IV期试验。
Patient Prefer Adherence. 2019 Dec 20;13:2195-2205. doi: 10.2147/PPA.S229536. eCollection 2019.
9
Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With Easypod Connect.生长激素缺乏成年患者替代治疗中依从性监测的相关性:使用Easypod Connect的单中心初步数据
Front Endocrinol (Lausanne). 2019 Jun 28;10:416. doi: 10.3389/fendo.2019.00416. eCollection 2019.
10
Optimizing Patient Management and Adherence for Children Receiving Growth Hormone.优化接受生长激素治疗儿童的患者管理与依从性
Front Endocrinol (Lausanne). 2017 Nov 20;8:313. doi: 10.3389/fendo.2017.00313. eCollection 2017.
无针注射对于儿童生长激素治疗来说是一种有用的替代方法吗?与细针相比,一种新型无针注射装置递送生长激素的安全性和药代动力学。
J Pediatr Endocrinol Metab. 2003 Mar;16(3):383-92. doi: 10.1515/jpem.2003.16.3.383.
4
Growth hormone deficiency and vascular risk.
Clin Endocrinol (Oxf). 2002 Jul;57(1):11-24. doi: 10.1046/j.1365-2265.2002.01559.x.
5
Clinical testing results and high patient satisfaction with a new needle-free device for growth hormone in young children.针对幼儿生长激素的新型无针设备的临床试验结果及患者高满意度。
Endocrine. 2001 Jun;15(1):15-7. doi: 10.1385/ENDO:15:1:015.
6
Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin.注射持续时间对皮下注射肝素所致局部疼痛强度及瘀斑的影响。
J Adv Nurs. 2001 Sep;35(6):882-92. doi: 10.1046/j.1365-2648.2001.01925.x.
7
The psychological consequences and quality of life in adults with growth hormone deficiency.成人生长激素缺乏症患者的心理后果及生活质量
Growth Horm IGF Res. 2000 Apr;10 Suppl B:S63-8. doi: 10.1016/s1096-6374(00)80012-x.
8
Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies.克雅氏病及相关传染性海绵状脑病
N Engl J Med. 1998 Dec 31;339(27):1994-2004. doi: 10.1056/NEJM199812313392707.
9
Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience.特纳综合征女童的生长激素治疗:国家合作生长研究经验
Pediatrics. 1998 Aug;102(2 Pt 3):479-81.
10
Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.在人生长激素治疗中,对无针Medi-Jector或多剂量Disetronic注射笔的心理反应。
Acta Paediatr. 1998 Feb;87(2):154-8. doi: 10.1080/08035259850157589.